Manchester Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $979 | Buy |
3
+1
| +50% | +$326 | ﹤0.01% | 1062 |
|
|
2025
Q1 | $541 | Hold |
2
| – | – | ﹤0.01% | 1081 |
|
|
2024
Q4 | $471 | Hold |
2
| – | – | ﹤0.01% | 1084 |
|
|
2024
Q3 | $551 | Hold |
2
| – | – | ﹤0.01% | 1076 |
|
|
2024
Q2 | $486 | Sell |
2
-1
| -33% | -$243 | ﹤0.01% | 1061 |
|
|
2024
Q1 | $449 | Hold |
3
| – | – | ﹤0.01% | 948 |
|
|
2023
Q4 | $575 | Hold |
3
| – | – | ﹤0.01% | 899 |
|
|
2023
Q3 | $532 | Hold |
3
| – | – | ﹤0.01% | 896 |
|
|
2023
Q2 | $570 | Buy |
+3
| New | +$570 | ﹤0.01% | 868 |
|
|
2020
Q4 | – | Sell |
-3
| Closed | – | – | 726 |
|
|
2020
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 545 |
|